Flexion Therapeutics Inc (FLXN)

20.60
NASDAQ : Health Care
Prev Close 20.60
Day Low/High 0.00 / 0.00
52 Wk Low/High 8.16 / 29.41
Avg Volume 499.90K
Exchange NASDAQ
Shares Outstanding 31.73M
Market Cap 823.76M
EPS -2.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Shark Bites: You Don't Want to Play the Gambler Today

Shark Bites: You Don't Want to Play the Gambler Today

This is one of those days when it may pay to walk away.

Second-Quarter Picks and Pans

Second-Quarter Picks and Pans

Las Vegas Sands and Flexion are in, and the autos are out.

I'm Big on Housing Entering Quarter No. 2

I'm Big on Housing Entering Quarter No. 2

Home builders make up the second-largest allocation in my portfolio, behind biotech.

How I'd Play Biotech Buyout Rumors

How I'd Play Biotech Buyout Rumors

Answering questions from the Biotech Mailbag on FLXN and SGYP.

How I'd Play Biotech Buyout Rumors

How I'd Play Biotech Buyout Rumors

Answering questions from the Biotech Mailbag on FLXN and SGYP.

Stocks Fall as House Leaders Delay Health Care Vote

Stocks Fall as House Leaders Delay Health Care Vote

Stocks fall on Thursday afternoon after House leaders delay a highly anticipated vote on the Republicans' repeal-and-replace health care bill.

Noteworthy Thursday Option Activity: FLXN, Z, SWC

Noteworthy Thursday Option Activity: FLXN, Z, SWC

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Flexion Therapeutics, Inc. , where a total volume of 1,667 contracts has been traded thus far today, a contract volume which is representative of approximately 166,700 underlying shares (given that every 1 contract represents 100 underlying shares).

Health Care Vote Impacts Trump's Deal Maker Image

Health Care Vote Impacts Trump's Deal Maker Image

At stake is whether the Republicans can work out their differences.

Sanofi Said to Be Near $1 Billion Deal for Flexion

Sanofi Said to Be Near $1 Billion Deal for Flexion

Flexion is an arthritis-focused biotech company.

Flexion Therapeutics Stock Sees Short Interest Decline 20%

Flexion Therapeutics Stock Sees Short Interest Decline 20%

The most recent short interest data has been released for the 11/30/2016 settlement date, which shows a 254,831 share decrease in total short interest for Flexion Therapeutics, Inc. , to 1,028,455, a decrease of 19.86% since 11/15/2016.

Commit To Buy Flexion Therapeutics At $10, Earn 17% Annualized Using Options

Commit To Buy Flexion Therapeutics At $10, Earn 17% Annualized Using Options

Investors considering a purchase of Flexion Therapeutics, Inc. shares, but tentative about paying the going market price of $17.89/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Flexion Therapeutics Announces Presentation Of Phase 3 Data Demonstrating That Extended-Release Zilretta™ Achieves Clinically Significant Improvement Of Pain, Stiffness And Function In Patients With Osteoarthritis Of The Knee

Flexion Therapeutics Announces Presentation Of Phase 3 Data Demonstrating That Extended-Release Zilretta™ Achieves Clinically Significant Improvement Of Pain, Stiffness And Function In Patients With Osteoarthritis Of The Knee

Podium Presentation at the AAHKS Annual Meeting Shows Zilretta Delivers Extended Relief Compared to Immediate-Release Steroid and Placebo

Insiders Seeing Green With FLXN At New 52-Week High

Insiders Seeing Green With FLXN At New 52-Week High

In trading on Thursday, shares of Flexion Therapeutics, Inc. touched a new 52-week high of $22.00/share.